bosentan anhydrous has been researched along with Esophageal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Fukui, Y; Hirabayashi, M; Miura, S; Miyagawa, T; Nakamura, K; Saigusa, R; Sato, S; Yamashita, T; Yoshizaki, A | 1 |
1 other study(ies) available for bosentan anhydrous and Esophageal Diseases
| Article | Year |
|---|---|
A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis.
Topics: Aged; Biomarkers; Bosentan; Endothelin Receptor Antagonists; Epithelium; Esophageal Diseases; Female; Galectins; Gene Expression Regulation; Humans; Keratinocytes; Male; Middle Aged; Pigmentation; Scleroderma, Systemic; Skin | 2019 |